PA
LLY icon

ProCore Advisors’s Eli Lilly LLY Stock Holding History

ProCore Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$908K Buy
756
+28
+4% +$28.6K 1.13% 20
2026
Q1 		$670K Sell
728
-56
-7% -$56.8K 1.03% 21
2025
Q4 		$843K Buy
+784
New +$750K 0.86% 26

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

ProCore Advisors's LLY Position: Q2 2026 in Review

ProCore Advisors increased its Eli Lilly (LLY) stake by 3.8% in Q2 2026, buying an estimated $28.6K and bringing the position to 756 shares worth $908K. The position accounts for 1.13% of the portfolio, ranked #20.

ProCore Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 3,075 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • ProCore Advisors held 756 shares of Eli Lilly worth $908K as of Q2 2026.
  • ProCore Advisors bought 28 Eli Lilly shares in Q2 2026, an estimated $28.6K.
  • Eli Lilly made up 1.13% of ProCore Advisors's portfolio in Q2 2026, its #20 holding.
  • ProCore Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 3,075 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on ProCore Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.